Novartis | NOVN

Stock Price
125.70
Daily Change
2.51 2.04%
Monthly
4.51%
Yearly
36.41%
Q3 Forecast
122.48

EPS Reference Time Actual Consensus Previous
2026-07-21 FY2026Q2 2.41 2.42
2026-04-28 FY2026Q1 1.99 2.28
2026-04-02 FY2025Q4 2.03 1.98
2025-10-28 FY2025Q3 2.04 1.58
2025-07-17 FY2025Q2 AM 2.42 1.97



Peers Price Chg Day Year Date
AbbVie 256.13 2.75 1.09% 36.89% Jul/21
Alcon AG 55.82 -0.94 -1.66% -19.78% Jul/21
Almirall 10.90 -0.04 -0.37% 3.02% Jul/21
Amgen 362.45 -1.72 -0.47% 18.57% Jul/21
Autolus Therapeutics Ltd 1.40 -0.04 -2.78% -41.91% Jul/20
AstraZeneca 12,492.00 112.00 0.90% 20.67% Jul/21
Bayer 47.62 0.31 0.66% 71.26% Jul/21
Biogen 202.74 2.79 1.40% 58.58% Jul/21
Bristol-Myers Squibb 60.88 0.72 1.20% 26.78% Jul/21
Fresenius Medical Care 43.28 1.01 2.39% -5.07% Jul/21

Indexes Price Day Year Date
CH20 14298 43.90 0.31% 20.22% Jul/21
EU600 643 3.60 0.56% 18.16% Jul/21

Novartis traded at 125.70 this Tuesday July 21st, increasing 2.51 or 2.04 percent since the previous trading session. Looking back, over the last four weeks, Novartis gained 4.51 percent. Over the last 12 months, its price rose by 36.41 percent. Looking ahead, we forecast Novartis to be priced at 122.48 by the end of this quarter and at 115.20 in one year, according to Trading Economics global macro models projections and analysts expectations.

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.



News Stream
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 131.60 CHF. Over the past 4 weeks, Novartis gained 13.16%, and in the last 12 months, it increased 32.71%.
2026-07-02
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 117.46 CHF. Over the past 4 weeks, Novartis gained 5.76%, and in the last 12 months, it increased 20.06%.
2026-02-02
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 116.82 CHF. Over the past 4 weeks, Novartis gained 6.24%, and in the last 12 months, it increased 26.31%.
2026-01-27